SPONSOR
Duke University
Total Trials
28
Recruiting
28
Phases
Phase 2, Phase 1, Phase 2, Phase 4, EARLY_Phase 1
Conditions studied: Cervical CancerHPVmHealthCancerCognitive ImpairmentPancreatitisBRCA1 MutationBRCA2 MutationEarly MenopausePremature Menopause
Duke University is a clinical research sponsor with 28 registered studies on ClinicalTrials.gov, of which 28 are actively recruiting participants. Research covers conditions including Cervical Cancer, HPV, mHealth, Cancer.
The trial portfolio spans Phase 2, Phase 1, Phase 2, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Duke University
How many clinical trials has Duke University sponsored?
ClinicalMetric currently tracks 28 clinical trials sponsored by Duke University, of which 28 are actively recruiting participants. These trials cover conditions including Cervical Cancer, HPV, mHealth. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Duke University research focus on?
Duke University clinical trials span Cervical Cancer, HPV, mHealth, Cancer, Cognitive Impairment, and additional conditions. The research pipeline includes Phase 2, Phase 1, Phase 2, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Duke University clinical trial?
To participate in a Duke University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Duke University trials with current recruitment status updated daily.
Clinical Trials by Duke University
NCT05848557
Recruiting
mSaada: A Mobile Health Tool
Cervical Cancer
NCT05144516
Recruiting
Cancer and Mild Cognitive Impairment Dyadic Intervention
Cancer
NCT07681050 Phase 2
Recruiting
Phosphate in Acute Pancreatitis
Pancreatitis
NCT06972719
Recruiting
Hormone Replacement Therapy After Risk Reducing Salpingo-oophorectomy
BRCA1 Mutation
NCT06982677
Recruiting
Improving Outcomes in Early Menopause After Cancer
Early Menopause
NCT07136428 Phase 1, Phase 2
Recruiting
Asciminib in HER2+ Breast Cancer Brain Metastases
HER2+ Metastatic Breast Cancer
NCT07632248
Recruiting
A Randomized Controlled Trial Testing a Digital, Gamified Early Intervention for Eating Disorders ("FlexED")
Eating Disorders
NCT01665326
Recruiting
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
Pompe Disease
NCT06986967
Recruiting
Retrograde Versus Antegrade Perfusion in Low-Moderate Hypothermia for Aortic Arch Surgery
Brain Function
NCT06638892
Recruiting
Using PrEP, Doing It for Ourselves
HIV Prevention
NCT03713268
Recruiting
Intraoperative OCT Guidance of Intraocular Surgery II
Macular Holes
NCT06854718
Recruiting
Pain With Dementia
Pain
NCT02237625
Recruiting
Natural History Study of Patients With Hypophosphatasia (HPP)
Hypophosphatasia
NCT00512694
Recruiting
Duke Lupus Registry
Systemic Lupus Erythematosus
NCT06331364
Recruiting
TREATment of Lower Respiratory Tract Infection in Selected Hospitals in Southern Sri Lanka (TREAT-SL): a Stepped-Wedge Cluster Randomized Trial
Lower Resp Tract Infection
NCT02127398 Phase 2
Recruiting
Stool Transplants to Treat Refractory Clostridium Difficile Colitis
Clostridium Difficile Colitis
NCT06795152
Recruiting
Rare Glycogen Storage Diseases Natural History Study
Glycogen Storage Disease
NCT04454203 Phase 4
Recruiting
Femoral Peri-arterial Local Anesthetic Injection Via Peri-arterial Perineural Catheter Reverses Tourniquet Associated Ischemic Hypertension
Tourniquet Hypertension
NCT06731504 EARLY_Phase 1
Recruiting
HMCT/CT2401: Abatacept GVHD Prophylaxis Following Omidubicel HCT
Hematologic Malignancy
NCT05712057
Recruiting
Neurostimulation Versus Therapy for Problems With Emotions
Emotion Regulation
NCT00360646
Recruiting
Drug-Induced Liver Injury (DILI) Network Retrospective
Drug Induced Liver Injury
NCT06139458
Recruiting
Cryocompression to Reduce Chemotherapy-induced Peripheral Neuropathy in Gynecologic Cancer - COHORT 2
Gynecologic Cancer
NCT05540704
Recruiting
Study Comparing Acceptance and Commitment Therapy to Supportive Diabetes Counseling and a Waitlist Control for Eating Disorders in Type 1 Diabetes
Type 1 Diabetes
NCT07215507
Recruiting
Timing of Physician Rounds for Antepartum Patients
Physician Rounds
NCT06164028
Recruiting
COA-APTIC Cognitive Interview Study of Caregiver and Clinician Assessment of Acute Pain in Infants and Young Children
Acute Pain
NCT07158814 Phase 4
Recruiting
Safety of RSV Preventive Monoclonal Antibody
Fever
NCT07234201
Recruiting
Virtual Reality Use for ICU Mobility
Intensive Care Unit ICU
NCT06521086
Recruiting
Optimizing Recovery in Trauma Patients by Integrating Enhanced Nutrition Delivery
Trauma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology